(Q37017289)

17 August 2017

1 reference

21 December 2019

A review of a bi-layered living cell treatment (Apligraf) in the treatment of venous leg ulcers and diabetic foot ulcers (English)

1 reference

17 August 2017

1 reference

21 December 2019

1 reference

17 June 2019

1 reference

16 November 2019

1 reference

Larissa Zaulyanov

1

1 reference

17 August 2017

Robert S Kirsner

series ordinal

2

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

Clinical Interventions in Aging

17 August 2017

10 references

17 August 2017

12 March 2019

13 March 2019

14 March 2019

22 March 2019

24 March 2019

25 April 2019

17 June 2019

16 November 2019

21 December 2019

2

1 reference

17 August 2017

1

1 reference

17 August 2017

93-98

1 reference

The diabetic foot: the importance of biofilms and wound bed preparation

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684073

Risk assessment of the diabetic foot and wound

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684073

Best-practice algorithms for the use of a bilayered living cell therapy (Apligraf) in the treatment of lower-extremity ulcers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684073

Venous ulcers: pathophysiology and treatment options

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684073

Protocol for the successful treatment of venous ulcers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684073

Clinical and economic impact of Apligraf for the treatment of nonhealing venous leg ulcers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684073

Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684073

The cost-effectiveness of wound management protocols of care.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684073

Neurovascular disease, antioxidants and glycation in diabetes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684073

Ulcerative sarcoidosis successfully treated with apligraf

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684073

Full-thickness burn of the foot: successful treatment with Apligraf. A case report.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684073

The use of tissue-engineered skin (Apligraf) to treat a newborn with epidermolysis bullosa

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684073

Evaluation of tissue-engineered skin (human skin substitute) and secondary intention healing in the treatment of full thickness wounds after Mohs micrographic or excisional surgery

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684073

The effect of a tissue engineered bilayered living skin analog, over meshed split-thickness autografts on the healing of excised burn wounds. The Apligraf Burn Study Group.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684073

Evaluation of Apligraf persistence and basement membrane restoration in donor site wounds: a pilot study.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684073

Quality of life of adults with unhealed and healed diabetic foot ulcers.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684073

Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684073

The cost effectiveness of Apligraf treatment of diabetic foot ulcers.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684073

Orchestrating Wound Healing: Assessing and Preparing the Wound Bed

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684073

Repair of cicatricial ectropion in an infant with harlequin ichthyosis using engineered human skin.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684073

Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684073

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684073

Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684073

An economic assessment of Apligraf (Graftskin) for the treatment of hard-to-heal venous leg ulcers

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684073

Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684073

Modulating diseased skin with tissue engineering: actinic purpura treated with Apligraf

4 September 2018

1 reference

https://api.crossref.org/works/10.2147%2FCIIA.2007.2.1.93

The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejection

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FCIIA.2007.2.1.93

Acute excisional wounds treated with a tissue-engineered skin (Apligraf)

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FCIIA.2007.2.1.93

Wounding of bioengineered skin: cellular and molecular aspects after injury

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FCIIA.2007.2.1.93

Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FCIIA.2007.2.1.93

Hydroxyurea-induced leg ulcers treated with Apligraf

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FCIIA.2007.2.1.93

Use of tissue-engineered skin in the dermal atrophy patient with traumatic avulsion injuries

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FCIIA.2007.2.1.93

Ulcers caused by bullous morphea treated with tissue-engineered skin

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FCIIA.2007.2.1.93

Behavior of tissue-engineered skin: a comparison of a living skin equivalent, autograft, and occlusive dressing in human donor sites

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FCIIA.2007.2.1.93

The longevity of a bilayered skin substitute after application to venous ulcers

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FCIIA.2007.2.1.93

Apligraf--a living human skin equivalent for the treatment of chronic wounds

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FCIIA.2007.2.1.93

Tissue engineering in wound repair

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18044080

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A composite skin substitute (graftskin) for surgical wounds. A clinical experience

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18044080

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2147/CIIA.2007.2.1.93

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

18044080

1 reference